MX2010004998A - Catenados para inmunoestimulacion. - Google Patents

Catenados para inmunoestimulacion.

Info

Publication number
MX2010004998A
MX2010004998A MX2010004998A MX2010004998A MX2010004998A MX 2010004998 A MX2010004998 A MX 2010004998A MX 2010004998 A MX2010004998 A MX 2010004998A MX 2010004998 A MX2010004998 A MX 2010004998A MX 2010004998 A MX2010004998 A MX 2010004998A
Authority
MX
Mexico
Prior art keywords
nucleic acid
coding nucleic
multimeric
acid molecules
molecules
Prior art date
Application number
MX2010004998A
Other languages
English (en)
Inventor
Burghardt Wittig
Manuel Schmidt
Janine Loehr
Matthias Schroff
Christiane Kleuss
Original Assignee
Mologen Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mologen Ag filed Critical Mologen Ag
Publication of MX2010004998A publication Critical patent/MX2010004998A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/117—Nucleic acids having immunomodulatory properties, e.g. containing CpG-motifs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/111—General methods applicable to biologically active non-coding nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/17—Immunomodulatory nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/30—Special therapeutic applications
    • C12N2320/31—Combination therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)

Abstract

La invención se refiere a una molécula de ácido nucleico no codificante multimérica para modular la actividad del sistema inmune humano o animal, y a un procedimiento para su producción, y a una vacuna que contiene dicha molécula de ácido nucleico no codificante multimérica. Dichas moléculas de ácido nucleico no codificante multiméricas pueden ser moléculas de ácido nucleico no codificante constituidas por al menos dos de dichas moléculas (dímeros) o conjuntos de varias moléculas de ácido nucleico no codificante.
MX2010004998A 2007-11-07 2008-11-07 Catenados para inmunoestimulacion. MX2010004998A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07075967A EP2058397A1 (de) 2007-11-07 2007-11-07 Multimeres Assemblat zur Immunstimulation
PCT/EP2008/009618 WO2009059805A1 (de) 2007-11-07 2008-11-07 Catenate zur immunstimulation

Publications (1)

Publication Number Publication Date
MX2010004998A true MX2010004998A (es) 2010-08-02

Family

ID=38990155

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010004998A MX2010004998A (es) 2007-11-07 2008-11-07 Catenados para inmunoestimulacion.

Country Status (13)

Country Link
US (1) US20100303803A1 (es)
EP (2) EP2058397A1 (es)
JP (1) JP2011502492A (es)
KR (1) KR20100087359A (es)
CN (1) CN101883854A (es)
AU (1) AU2008324384A1 (es)
BR (1) BRPI0820388A2 (es)
CA (1) CA2703983A1 (es)
EA (1) EA201000769A1 (es)
IL (1) IL205543A0 (es)
MX (1) MX2010004998A (es)
TW (1) TW200927148A (es)
WO (1) WO2009059805A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2246433A1 (de) * 2009-04-30 2010-11-03 Mologen AG Concatemere zur Immunmodulation
US20130245102A1 (en) * 2010-10-12 2013-09-19 Research Foundation Of The City University Of New York Novel dna templates for small rna production in mammalian cells
EP3164113B1 (en) 2014-06-04 2019-03-27 Exicure, Inc. Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications
LU92821B1 (en) 2015-09-09 2017-03-20 Mologen Ag Combination comprising immunostimulatory oligonucleotides
GB2542425A (en) 2015-09-21 2017-03-22 Mologen Ag Means for the treatment of HIV
US11364304B2 (en) 2016-08-25 2022-06-21 Northwestern University Crosslinked micellar spherical nucleic acids
WO2018209270A1 (en) 2017-05-11 2018-11-15 Northwestern University Adoptive cell therapy using spherical nucleic acids (snas)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19935756A1 (de) * 1999-07-27 2001-02-08 Mologen Forschungs Entwicklung Kovalent geschlossenes Nukleinsäuremolekül zur Immunstimulation
EP1716234B1 (de) * 2004-02-20 2013-10-02 Mologen AG Substituiertes, nicht-kodierendes nukleinsäuremolekül zur therapeutischen und prophylaktischen immunstimulation in menschen und höheren tieren
WO2006015560A1 (de) * 2004-08-09 2006-02-16 Mologen Ag Immunmodulierendes mittel in verbindung mit chemotherapeutischen massnahmen
BRPI0711607A2 (pt) * 2006-05-11 2012-11-06 Mologen Ag molécula multimérica para modulação da atividade do sistema imunológico humano ou animal, agente de combinação, kit, agente farmacêutico, molécula e uso da mesma

Also Published As

Publication number Publication date
KR20100087359A (ko) 2010-08-04
TW200927148A (en) 2009-07-01
EA201000769A1 (ru) 2010-12-30
US20100303803A1 (en) 2010-12-02
AU2008324384A1 (en) 2009-05-14
WO2009059805A1 (de) 2009-05-14
EP2058397A1 (de) 2009-05-13
IL205543A0 (en) 2010-12-30
BRPI0820388A2 (pt) 2014-10-14
EP2207880A1 (de) 2010-07-21
CN101883854A (zh) 2010-11-10
JP2011502492A (ja) 2011-01-27
CA2703983A1 (en) 2009-05-14

Similar Documents

Publication Publication Date Title
ES2357692T3 (es) Multimero para la inmunoestimulacion.
MX2010004998A (es) Catenados para inmunoestimulacion.
SG10201804869UA (en) Purification of biological molecules
UA117098C2 (uk) Сполука, що містить модифікований олігонуклеотид
UA115652C2 (uk) Сполука, що містить модифікований олігонуклеотид, комплементарна mir-21
PH12014501702A1 (en) Imidazopyrrolidinone compounds
WO2012177639A3 (en) Bioprocessing and bioproduction using avian cell lines
EA201492057A1 (ru) Ферментация и способ с псевдодвижущимся слоем
MX2013002255A (es) Moduladores de proteina de notum y metodos de uso.
MX2015006289A (es) Composiciones y metodos para la modulacion de la expresion del receptor del factor de crecimiento de fibroblastos tipo 3 (fgfr3).
MX2012004078A (es) Compuestos y composiciones como moduladores de la actividad de gpr119.
MY160401A (en) Concatamers for immunemodulation
HUE049168T2 (hu) L-aminosav elõállítására képes mikroorganizmus és eljárás L-aminosav elõállítására annak alkalmazásával
MX2015003077A (es) Metodo para preparar mentona a partir de isopulegol.
MY182946A (en) Production of organic acids by fermentation at low ph
IL192333A0 (en) Photobioreactor, system and method for the cultivation of microalgae
MX349801B (es) Sustratos de enzimas de ácido nucleico.
MY149171A (en) Treatment and prevention of influenza
PH12014502243A1 (en) Novel bacillus subtilis
MX2014007944A (es) Proteína quitinasa insecticida novedosa, su nucleótido codificador y su aplicación.
HK1199831A1 (en) Composition for improving and or treating central nervous system degenerative disease
WO2012138708A8 (en) Mhc engagement and clip modulation for the treatment of disease
GB2475627A (en) Resource-availability system and method
WO2011103028A3 (en) Compositions and methods for inhibiting mmset
IN2014DN05672A (es)

Legal Events

Date Code Title Description
FA Abandonment or withdrawal